Business
2022 Interim Results
2022 Interim Results.
About this update from Rentokil Initial Plc
[{"type":"text","content":"\n \n \n 2022 Interim Results\n Excellent momentum continued in first half with strong revenue growth and pricing fully offsetting inflation.\nPerformance supported by proven and resilient business model.\nKey milestones reached in Terminix transaction.\n \n \n \n \n Financial Results*\n \n \n H1 2022\n \n \n Growth\n \n \n \n \n £m\n \n \n AER\n \n \n AER\n \n \n CER\n \n \n \n \n Ongoing Revenue¹\n \n \n \n 1,571.2\n \n \n \n 8.1%\n \n \n 5.6%\n \n \n \n \n Ongoing Revenue excluding disinfection¹\n \n \n \n 1,557.4\n \n \n \n 14.7%\n \n \n 12.0%\n \n \n \n \n Ongoing Operating Profit\n \n \n \n 232.5\n \n \n \n 11.5%\n \n \n 9.6%\n \n \n \n \n Adjusted profit before tax\n \n \n \n 225.4\n \n \n \n 16.2%\n \n \n 14.7%\n \n \n \n \n Free Cash Flow\n \n \n \n 136.3\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Adjusted EPS\n \n \n \n 9.49p\n \n \n \n 14.1%\n \n \n 7.8%\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Statutory Results\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Revenue\n \n \n \n 1,572.1\n \n \n \n 8.1%\n \n \n 5.5%\n \n \n \n \n Operating Profit\n \n \n \n 169.7\n \n \n \n 5.6%\n \n \n 3.9%\n \n \n \n \n Profit before tax\n \n \n \n 161.9\n \n \n \n 8.8%\n \n \n 7.8%\n \n \n \n \n EPS\n \n \n \n 6.67p\n \n \n \n 4.0%\n \n \n \n \n \n \n \n \n \n \n \n Dividend per share\n \n \n \n 2.4p\n \n \n \n 15.0%\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 2022 Interim Highlights\n (Unless otherwise stated, all figures are presented at constant exchange rates and revenue growth figures exclude the disinfection business).\n \n \n \n \n \n ●\n \n \n \n Strong topline momentum continues: Ongoing Revenue excluding disinfection up 12.0%, Organic Revenue\n 2\n up 7.3%, driven by strong demand for our business services and demonstrable price progression. Total Revenue up 8.1% to £1,572.1m at AER\n \n \n \n \n \n \n \n \n \n \n \n \n -\n \n \n \n Ongoing Revenue including disinfection up 5.6%. £13.6m revenues from disinfection, with substantial reduction in the period as anticipated (H1 21: £95.3m)\n \n \n \n \n \n \n \n \n \n \n \n \n -\n \n \n \n In North America Organic Revenue up 6.4% and Ongoing Revenue excluding disinfection up 12.5%\n \n \n \n \n \n ●\n \n \n \n Broad-based growth across business cate...